This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vilnius University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Gene Editing: The Contributions of Monika Gasiuniene
Introduction
Monika Gasiuniene, an innovative researcher based in Vilnius, Lithuania, has made significant strides in the field of gene editing. Her work primarily focuses on the CRISPR/Cas system, which has transformed genetic engineering and molecular biology. With one patent to her name, Gasiuniene is recognized for her contributions to the development of advanced methods for site-specific modification of DNA.
Latest Patents
Gasiuniene's patent, titled "RNA-directed DNA cleavage by the Cas9-crRNA complex," outlines a groundbreaking approach to DNA modification. This patent addresses the isolation and assembly of the Cas9-crRNA complex, which facilitates the cleavage of DNA sequences complementary to the crRNA. Furthermore, it includes innovative methods for utilizing RNA-guided DNA endonucleases and reprogramming Cas9-crRNA complex specificity, showcasing the versatility and potential applications of this technology in various biological settings.
Career Highlights
As a dedicated researcher at Vilnius University, Monika Gasiuniene has cultivated a dynamic academic and professional career. Her focus on cutting-edge gene editing techniques has positioned her as a prominent figure in molecular biology. The development of her patented methodologies has garnered attention within the scientific community, contributing to ongoing research in genetic engineering and therapies.
Collaborations
Gasiuniene has collaborated with esteemed colleagues, including Virginijus Siksnys and Giedrius Gasiunas, who have been instrumental in advancing the understanding of the CRISPR/Cas system. These collaborations enhance her research impact, as they combine expertise from multiple fields and contribute to novel innovations in the applications of gene editing technologies.
Conclusion
Monika Gasiuniene's contributions to the field of gene editing through her innovative patent highlight her role as a key player in scientific advancement. Her work continues to inspire and drive research forward, as the CRISPR/Cas technology evolves. With her ongoing collaborations and commitment to exploration, Gasiuniene’s future endeavors promise to further enhance the landscape of genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile